STAT+: Pharmalittle: J&J is third drugmaker to sue over Medicare negotiations; Teva faces trial over Medicare kickbacks
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
Category: Medicine
STAT+: States increasingly look to regulate hospital facility fees
Unexpected “facility fees” charged by hospitals have become a growing source of rage for patients,…
Cancer drug shortages deliver ‘gut punch’ to patients unsure if their survival odds will be undercut
Mairéad McInerney will never know if changes in her treatment plan have undercut her odds…
Opinion: Policymakers who want to regulate AI need to start talking to health care industry representatives
Recently, the fervor over artificial intelligence has given way to expressions of fears of the…
STAT+: App developer Twill hunts for pharma partner to market its digital depression treatment
In another sign of the business headwinds facing prescription mental health apps, developer Twill will…
Opinion: Listen: Dance helped this nurse heal from trauma. Now she’s bringing it to others
“You can’t pour from an empty cup” is what registered nurse Tara Rynders learned the…
STAT+: To get better heart data from wearables, researchers train AI to separate the signal from the noise
As wearable health devices grow more popular in the U.S., there’s a growing opportunity to…
STAT+: Bernie Sanders adds three drug shortage policies to pandemic preparedness bill
WASHINGTON — Senate health committee Chair Bernie Sanders added three drug shortage measures to a…
STAT+: At Orexo, a ‘turning point’ for everything but digital health
Most everything is looking up for Orexo, the company reported on its second quarter earnings…
A new study shows how Medicaid coverage policies shape maternal health disparities
Medicaid is an essential source of maternal and postpartum care for low-income Americans, covering 42%…
.jpg)
STAT+: Johnson & Johnson sues to stop Medicare negotiation
WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the…
STAT+: ‘Doctors need to get on top of this’: GPT-4 displays bias in medical tasks
Diagnosis is an especially tantalizing application for generative AI: Even when given tough cases that…
STAT+: Novartis is scolded by U.K. trade group for the third time this year over Entresto marketing
For the third time this year, Novartis has been rebuked by a U.K. trade group…
STAT Virtual Event: The State of Biosimilars: What to Watch
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. Now…
STAT+: Pharmalittle: Data confirm benefits and risks of Lilly Alzheimer’s drug; Medicare aims to pay hospitals to stockpile essential drugs
Rise and shine, everyone, another busy day is on the way. We can tell because…
ARCH Venture Partners rises to the top of STAT’s 2023 biotech VC rankings
This article is adapted from the 2023 edition of STAT’s annual report, “Ranking biotech’s top…
STAT+: Flagship, Pfizer team up in deal worth $7 billion
Pharma giant Pfizer is turning to venture firm Flagship for new drug development, signing a…
STAT+: Startup Neumora takes a novel depression drug to Phase 3
Neumora, a privately held biotech company, is moving into the final phase of testing with…
STAT+: As digital health tech proliferates, a new institute aims to cut through hype
A new $50 million nonprofit initiative aims to independently evaluate health technologies’ impact on costs…
From rapid cooling body bags to ‘prescriptions’ for AC, doctors prepare for a future of extreme heat
In Phoenix, where daytime temperatures are topping 110 degrees Fahrenheit for the third straight week,…
STAT+: Conservative group opposing PBM reform spends record number on lobbying
WASHINGTON — A conservative group advocating against changing how pharmacy middlemen operate spent more than…
STAT+: Medicare has a new plan to address drug shortages — but it could backfire
WASHINGTON — Medicare has a new proposal to pay hospitals more to stockpile essential drugs…
Opinion: AI can’t replicate this key part of practicing medicine
I’ve heard “WebMD said it could be cancer” countless times in my 15 years working…
Hearing aids may slow mental decline in those at higher risk of dementia, study finds
Doctors have long suspected that hearing loss in older adults hastens dementia, the cognitive decline…
Global childhood vaccinations edge closer to pre-pandemic levels: WHO report
Global childhood immunization coverage has nearly rebounded to pre-pandemic levels, according to a new report,…
STAT+: Medicare to cover more brain scans for Alzheimer’s patients
WASHINGTON — Medicare on Monday proposed ending restrictions on how many PET scans patients can…
STAT+: Key House panel plots a new health care package — complicating the chamber’s agenda
WASHINGTON — It’s two weeks until Congress leaves town in August, and a prominent House panel…
STAT+: Colombian government explores compulsory licensing for an HIV drug
The latest clash over the cost of a prescription medicine is playing out in Colombia,…
FDA approves RSV monoclonal antibody for infants, young children at high risk
The Food and Drug Administration approved a monoclonal antibody to protect infants and young children…
Nearly 8,000 blood tests recalled over risk of missed heart attack diagnosis
QuidelOrtho has recalled nearly 8,000 potentially faulty blood tests meant to help doctors quickly determine…
STAT+: Electronic health record maker NextGen Healthcare to pay $31 million to resolve fraud claims
The health records company NextGen Healthcare will pay $31 million to resolve allegations that it…
STAT+: Sanofi licenses CRISPR enzyme in bid to develop safer, simpler sickle cell cure
Sanofi will license a new CRISPR enzyme from the startup Scribe Therapeutics in a bid…
STAT+: Detailed data confirm benefits — and risks — of Eli Lilly’s Alzheimer’s drug
The benefits and risks of Eli Lilly’s treatment for Alzheimer’s disease were confirmed in detailed…
STAT+: Pharmalittle: Alzheimer’s diagnosis revamp embraces rating scale similar to cancer; FTC seeks info on Pfizer-Seagen deal
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
.jpg)
STAT+: BridgeBio heart drug succeeds in pivotal study
A drug developed by the biotech firm BridgeBio to treat an increasingly common heart condition…
STAT+: Westlake Village, a West Coast VC firm, raises $450 million fund
Westlake Village BioPartners, a West Coast biotech venture capital firm founded five years ago by…
STAT+: Blue Cross Blue Shield plans in California evaded $170 million in taxes, whistleblower says
Two dominant Blue Cross Blue Shield companies in California intentionally underreported premiums of certain health…
How telehealth startups are trying to fill the menopause care vacuum
At the turn of the century, nearly 18 million women in the United States were…
Opinion: No one — M.D. or otherwise — should use the honorific ‘doctor’ with patients
Florida legislators recently passed legislation to prevent advanced practice nurses in Florida with doctorates from…
Listen: Wildfire pollution widens asthma inequities on Long Island
Wyandanch is a proud, resilient community on Long Island. There’s about 13,000 people who live…
For a 9-year-old patient at a Los Angeles obesity clinic, barriers to health are everywhere
This is part of a series about new obesity drugs that are transforming patients’ lives,…
STAT+: As fear rises over AI, Google and Epic fight stronger regulation of the technology in health care
Big businesses poised to profit from the advance of artificial intelligence in health care are…
STAT+: Argenx antibody drug significantly slows progression of nerve disorder that robs patients of muscle strength
Belgian drugmaker Argenx said Monday that its antibody treatment called Vyvgart significantly delayed the progression…
Researchers turn to CRISPR to unlock one of the trickiest diseases to treat: Alzheimer’s
When the genome-editing tool CRISPR is thought of as a potential medicine, the targets that…
Celiac study examines precisely how gluten triggers injury to intestine
For a person with celiac disease, eating a bagel goes something like this: chewing and…
J&J expands global access to TB drug as popular novelist joins advocacy campaign
Advocates have been fighting Johnson & Johnson for years over a patent on a lifesaving…
STAT+: Demand spikes in seniors, behavioral health care challenge UnitedHealth’s provider arm
UnitedHealth Group’s Optum subsidiary saw a lower operating margin in the second quarter due to…
STAT+: Eli Lilly to acquire Versanis in heated race for weight loss drugs
Eli Lilly said Friday it will acquire Versanis Bio, a private company developing an obesity…
STAT+: Pharmalittle: Key Senate panel has a plan for PBMs; Roivant eyes $7 billion sale of a stomach drug
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Three women sue cancer diagnostic firm Grail alleging harassment, retaliation
Three sales executives, all of them women, have filed suit against Grail, a cancer diagnostics…